Oxytrol for Women (oxybutynin) Transdermal System
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
DRUG FACTS LABEL
The warnings section is now to read:
“Sleepiness, dizziness, confusion, and blurry vision...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts